We are live on ! Find out more
VIVS

VivoSim Labs
VIVS

27 hedge funds and large institutions have $189K invested in VivoSim Labs in 2025 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 3 increasing their positions, 5 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

4.48% less ownership

Funds ownership: 8.49% → 4.01% (-4.5%)

7% less funds holding

Funds holding: 29 → 27 (-2)

29% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 7

40% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 5

71% less capital invested

Capital invested by funds: $644K → $189K (-$455K)

Holders
27
Holders Change
-2
Holders Change %
-6.9%
% of All Funds
0.33%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
3
Reduced
5
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
+$46.3K
2
Citigroup
Citigroup
New York
+$11.4K
3
Geode Capital Management
Geode Capital Management
Massachusetts
+$6.43K
4
TRCT
Tower Research Capital (TRC)
New York
+$1.63K
5
LFG
Larson Financial Group
Missouri
+$395

Top Sellers

Rank Fund Capital Flow
1
DS
DRW Securities
Illinois
-$197K
2
HF
HRT Financial
New York
-$92K
3
TSS
Two Sigma Securities
New York
-$53.2K
4
UBS Group
UBS Group
Switzerland
-$36.1K
5
Two Sigma Investments
Two Sigma Investments
New York
-$27K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$40.5K – – –
Geode Capital Management
2
Geode Capital Management
Massachusetts
$37.4K +$6.43K +2,704 +15%
Citadel Advisors
3
Citadel Advisors
Florida
$35.2K +$46.3K +19,449 New
Two Sigma Investments
4
Two Sigma Investments
New York
$21.4K -$27K -11,362 -49%
BlackRock
5
BlackRock
New York
$21.4K – – –
Northern Trust
6
Northern Trust
Illinois
$19.1K – – –
Citigroup
7
Citigroup
New York
$8.82K +$11.4K +4,803 +6,765%
TRCT
8
Tower Research Capital (TRC)
New York
$3.42K +$1.63K +687 +57%
SS
9
SBI Securities
Japan
$400 – – –
AF
10
Allworth Financial
California
$377 – – –
LFG
11
Larson Financial Group
Missouri
$300 +$395 +166 New
AFG
12
Albion Financial Group
Utah
$288 – – –
Wells Fargo
13
Wells Fargo
California
$211 -$5 -2 -2%
Osaic Holdings
14
Osaic Holdings
Arizona
$168 -$59 -25 -21%
Morgan Stanley
15
Morgan Stanley
New York
$123 – – –
FFA
16
Farther Finance Advisors
California
$105 – – –
Bank of America
17
Bank of America
North Carolina
$53 -$21 -9 -24%
UBS Group
18
UBS Group
Switzerland
$28 -$36.1K -15,200 -100%
JP Morgan Chase
19
JP Morgan Chase
New York
$5 – – –
FDCDDQ
20
Federation des caisses Desjardins du Quebec
Quebec, Canada
$4 – – –
GSWM
21
Golden State Wealth Management
California
$4 – – –
Rockefeller Capital Management
22
Rockefeller Capital Management
New York
$4 – – –
S
23
SignatureFD
Georgia
$4 – – –
HI
24
Harbour Investments
Wisconsin
$2 – – –
FCAS
25
First Command Advisory Services
Texas
$2 +$2 +1 New
1
2

VIVS Hedge Fund Activity: Q4 2025 in Review

27 of the 8,229 institutional investors tracked by Wall St. Rank reported a position in VivoSim Labs (VIVS) for Q4 2025, worth a combined $189K — down 71% from $644K a quarter earlier.

Sellers outnumbered buyers: 7 funds closed out of VIVS and 5 opened new positions — a net loss of 2 holders — while 5 trimmed existing stakes and 3 added.

The largest buyer was Citadel Advisors, opening a new position worth an estimated $46.3K. The largest seller was DRW Securities, exiting entirely with an estimated $197K sold.

  • 27 institutional investors held VivoSim Labs (VIVS) as of Q4 2025, down from 29 in Q3 2025.
  • Funds reported $189K of VivoSim Labs stock for Q4 2025, down 71% quarter-over-quarter.
  • 5 funds opened new VivoSim Labs positions in Q4 2025 and 7 closed out, a net change of -2 holders.
  • The largest VivoSim Labs buyer in Q4 2025 was Citadel Advisors, an estimated $46.3K added.
  • The largest VivoSim Labs seller in Q4 2025 was DRW Securities, an estimated $197K sold.

Based on aggregated 13F filings for Q4 2025.